The study of the ovarian proteomic profile represents a new frontier in ovarian cancer research, since this approach is able to enlighten the wide variety of post-translational events (such as glycosylation and phosphorylation). Due to the possibility of analyzing thousands of proteins, which could be simultaneously altered, comparative proteomics represent a promising model of possible biomarker discovery for ovarian cancer detection and monitoring. Moreover, defining signaling pathways in ovarian cancer cells through proteomic analysis offers the opportunity to design novel drugs and to optimize the use of molecularly targeted agents against crucial and biologically active pathways. Proteomic techniques provide more information about different histological types of ovarian cancer, cell growth and progression, genes related to tumor microenvironment and specific molecular targets predictive of response to chemotherapy than sequencing or microarrays. Estimates of specificity with proteomics are less consistent, but suggest a new role for combinations of biomarkers in early ovarian cancer diagnosis, such as the OVA1 test. Finally, the definition of the proteomic profiles in ovarian cancer would be accurate and effective in identifying which pathways are differentially altered, defining the most effective therapeutic regimen and eventually improving health outcomes.

Ovarian cancer: can proteomics give new insights for therapy and diagnosis? / Toss, Angela; DE MATTEIS, Elisabetta; Rossi, Elena; Casa, L. D.; Iannone, Anna; Federico, Massimo; Cortesi, Laura. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1661-6596. - ELETTRONICO. - 14:4(2013), pp. 8271-8290. [10.3390/ijms14048271]

Ovarian cancer: can proteomics give new insights for therapy and diagnosis?

TOSS, ANGELA;DE MATTEIS, Elisabetta;ROSSI, Elena;IANNONE, Anna;FEDERICO, Massimo;CORTESI, LAURA
2013

Abstract

The study of the ovarian proteomic profile represents a new frontier in ovarian cancer research, since this approach is able to enlighten the wide variety of post-translational events (such as glycosylation and phosphorylation). Due to the possibility of analyzing thousands of proteins, which could be simultaneously altered, comparative proteomics represent a promising model of possible biomarker discovery for ovarian cancer detection and monitoring. Moreover, defining signaling pathways in ovarian cancer cells through proteomic analysis offers the opportunity to design novel drugs and to optimize the use of molecularly targeted agents against crucial and biologically active pathways. Proteomic techniques provide more information about different histological types of ovarian cancer, cell growth and progression, genes related to tumor microenvironment and specific molecular targets predictive of response to chemotherapy than sequencing or microarrays. Estimates of specificity with proteomics are less consistent, but suggest a new role for combinations of biomarkers in early ovarian cancer diagnosis, such as the OVA1 test. Finally, the definition of the proteomic profiles in ovarian cancer would be accurate and effective in identifying which pathways are differentially altered, defining the most effective therapeutic regimen and eventually improving health outcomes.
2013
14
4
8271
8290
Ovarian cancer: can proteomics give new insights for therapy and diagnosis? / Toss, Angela; DE MATTEIS, Elisabetta; Rossi, Elena; Casa, L. D.; Iannone, Anna; Federico, Massimo; Cortesi, Laura. - In: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. - ISSN 1661-6596. - ELETTRONICO. - 14:4(2013), pp. 8271-8290. [10.3390/ijms14048271]
Toss, Angela; DE MATTEIS, Elisabetta; Rossi, Elena; Casa, L. D.; Iannone, Anna; Federico, Massimo; Cortesi, Laura
File in questo prodotto:
File Dimensione Formato  
ijms-14-08271.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 668.24 kB
Formato Adobe PDF
668.24 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/935289
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 25
social impact